COVID-19 Updates
Latest News
Getting Reluctant Patients to ‘Yes’ on COVID Vaccination
Be patient, acknowledge concerns, appeal to hearts not minds, and make it personal.
Latest News
Bivalent COVID Vaccine Protected Children, Adolescents
Children who received an mRNA bivalent vaccine were less likely to be infected than were unvaccinated peers or those who received only monovalent...
Feature
Five Bold Predictions for Long COVID in 2024
If even one of these comes true, long COVID sufferers could enjoy some much-needed relief.
Latest News
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
The cohort consisted of 259,369 patients with COVID-19 and 259,369 uninfected controls.
Latest News
COVID Strain JN.1 Is Now a ‘Variant of Interest,’ WHO Says
The variant accounted for an estimated 21% of cases for the 2-week period ending December 9, up from 8% during the 2 weeks prior.
Latest News
Federal program offers free COVID, flu at-home tests, treatments
“With its expansion, the Home Test to Treat program will now offer free testing, telehealth, and treatment for both COVID-19 and for influenza (...
Latest News
New COVID variant JN.1 could disrupt holiday plans
Nearly 10,000 people were hospitalized for COVID in the U.S. for the week ending Nov. 25, the CDC said, a 10%...
Latest News
Some reasons to get off the fence about COVID booster
“The body of evidence from all these different studies converge on one single reality — that vaccines reduce the risk of long COVID.”
From the Journals
COVID vaccines lower risk of serious illness in children
“The findings in this report support the recommendation for COVID-19 vaccination for all children aged ≥6 months and highlight the importance of...
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.